Peter J Wilkinson

CIK 1398138 · SVP, Chief Accounting Officer · last filed 2026-03-30

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$927.6K

Companies

2

Total Filings

47

Lifetime Open-Market Net

-$3.59M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LH SVP, Chief Accounting Officer 3,485 $266.16 $927.6K -$3.29M 37 2026-03-30
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted VP of Fin./Chief Acctg. Off. 828 -$299.5K 10 2009-01-05

Recent Filings · Page 4 of 5

47 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-19 LH Mixed +453 -$282.0K EDGAR
2021-02-08 LH Mixed +97 -$11.9K EDGAR
2021-02-04 LH Grant (A) $0 EDGAR
2020-08-18 LH Grant (A) $0 EDGAR
2020-02-25 LH Sell (S) −297 -$56.3K EDGAR
2020-02-14 LH Mixed +594 -$51.0K EDGAR
2020-02-06 LH Grant (A) $0 EDGAR
2009-01-05 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Disc (I) +354 $9.2K EDGAR
2008-11-21 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Grant (A) $0 EDGAR
2008-10-03 PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Grant (A) $0 EDGAR
Showing 3140 of 47
Page 4 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.